CenterBook Partners »

Silverback Therapeutics shares owned by CenterBook Partners

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by CenterBook Partners from 13F filings

Historical chart of CenterBook Partners investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by CenterBook Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by CenterBook Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.1M 512k 10.05

More positions owned by CenterBook Partners

Amazon (AMZN)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
Texas Instruments Incorporated (TXN)
Booking Holdings (BKNG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Snowflake Com Shs (SNOW)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Apple (AAPL)

View all positions for CenterBook Partners

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics